Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apovir for treatment of patients with Alzheimer's disease
2013-002126-23Phase 2Completed
- Sponsor
- Apodemus AB
- Start
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Alzheimer's disease (AD) comparing Apovir with Placebo (2 arms). Primary endpoint: ADAS-cog at 9 months. Started Jul 2013; status: completed.
02
Drugs
Apovir
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2013-002126-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002126-23.